Chemomab Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMMB and other ETFs, options, and stocks.

About CMMB

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

CEO

Adi Mor

CEOAdi Mor

Employees

Employees16

Headquarters

Tel Aviv, Tel Aviv

HeadquartersTel Aviv, Tel Aviv

Founded

2011

Founded2011

Employees

Employees16

CMMB Key Statistics

Market cap

22.64M

Market cap22.64M

Price-Earnings ratio

-1.59

Price-Earnings ratio-1.59

Dividend yield

—

Dividend yield—

Average volume

287.84K

Average volume287.84K

High today

$1.25

High today$1.25

Low today

$1.19

Low today$1.19

Open price

$1.25

Open price$1.25

Volume

94.74K

Volume94.74K

52 Week high

$2.55

52 Week high$2.55

52 Week low

$0.87

52 Week low$0.87

Chemomab Therapeutics

Why Robinhood?

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel. Show more

CMMB Key Statistics

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.